Table 2.
Relative Risks that compare all-cause mortality rates and major adverse cardiovascular event rates of various ABI groups to patients with normal ABI
| Mortality | ||||||
|---|---|---|---|---|---|---|
| Unadjusted | Adjusted* | |||||
| ABI group | RR | (95% CI) | p-value | RR | (95% CI) | p-value |
| Low ABI (<=0.9) High ABI (>1.3) Non-compressible artery |
2.16 1.24 2.93 |
1.66, 2.82 0.80, 1.92 2.03, 4.22 |
<.0001 0.34 <.0001 |
1.65 1.31 1.87 |
1.25, 2.18 0.84, 2.05 1.27, 2.75 |
.0005 0.24 .001 |
| Death, MI, and stroke | ||||||
| Unadjusted | Adjusted* | |||||
| ABI group | RR | (95% CI) | p-value | RR | (95% CI) | p-value |
| Low ABI (<=0.9) High ABI (>1.3) Non-compressible artery |
1.73 1.03 2.10 |
1.41, 2.12 0.73, 1.45 1.55, 2.83 |
<.0001 0.87 <.0001 |
1.37 1.11 1.51 |
1.10, 1.70 0.78, 1.58 1.10, 2.06 |
.004 0.55 .01 |
*
Adjusted for: Age, sex, black race, duration of diabetes, insulin therapy, glycated hemoglobin, body mass index, hypertension, smoking, hypercholesterolemia, chronic renal dysfunction, C reactive protein, albumin creatinine ratio, history of congestive heart failure, angina, peripheral neuropathy, left ventricular ejection fraction, myocardial jeopardy, and number of diseased regions.